Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

SHE:301617 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,536	1,465	1,328	1,025	798.47	524.37
Revenue Growth	14.57%	10.30%	29.53%	28.39%	52.27%	38.20%
Gross Profit Gross Profit Growth	295.31	295.56	328.55	285.75	277.67	177.33
Operating Income Operating Income Growth	196.93	195.41	241.77	209.64	207.33	124.89
Net Income Net Income Growth	174.25	172.29	212.84	182.1	176.32	103.29
Earnings Per Share EPS Growth	1.00	0.99	2.12	1.40	1.35	0.83
EPS Growth	-47.10%	-53.26%	52.03%	3.20%	63.88%	60.41%

Revenue by Geography

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China China Growth	1,447	1,299	992.4	792.46	520.83
Overseas Overseas Growth	17.25	29.27	32.75	6.01	3.54
Total Total Growth	1,465	1,328	1,025	798.47	524.37

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	612.62	656.27	958.58	228.52	149.15	70.02
Total Debt Total Debt Growth	1.21	1.83	0.27	0.53	2.58	2.9
Net Cash (Debt) Net Cash Growth	611.4	654.43	958.31	227.99	146.57	67.12
Net Cash Growth	-28.17%	-31.71%	320.32%	55.55%	118.37%	-
Net Cash Per Share Net Cash Per Share Growth	3.52	3.77	9.56	1.75	1.12	0.54

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	36.11	-2.97	161.76	146.23	188.95	79.51
Capital Expenditures CapEx Growth	-97.98	-85.1	-55.45	-66.98	-135.05	-67.93
Free Cash Flow Free Cash Flow Growth	-61.86	-88.07	106.31	79.26	53.9	11.58
Free Cash Flow Growth	-	-	34.14%	47.04%	365.44%	4.51%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	19.23%	20.18%	24.74%	27.87%	34.78%	33.82%
Operating Margin	12.83%	13.34%	18.21%	20.45%	25.97%	23.82%
Pretax Margin	13.05%	13.38%	18.40%	20.28%	25.21%	22.44%
Profit Margin	11.35%	11.76%	16.03%	17.76%	22.08%	19.70%
FCF Margin	-4.03%	-6.01%	8.01%	7.73%	6.75%	2.21%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep 3, 2026	Dec 31, 2025	Dec 31, 2024
Dividend Per Share Dividend Per Share Growth	0.300	0.308	0.355
Dividend Per Share Growth	-46.63%	-13.32%	-
Dividend Yield	0.59%	0.52%	1.20%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	50.80	60.32	24.74	-	-	-
Forward PE	-	43.09	-	-	-	-
P/FCF Ratio	-	-	49.53	-	-	-
PS Ratio	5.77	7.10	3.97	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error